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Thank you to all those who make the choice to 
access our services, trust us to help with their 
challenges and welcome us into their lives. 
Chairperson’s Report
Welcome to the Ana Liffey Drug Project’s Annual Report for 2018. As always, it was a busy year, 
with lots of activity. During 2018, the organisation progressed a number of items under our 
current strategic plan – Safer From Harm – and this work will continue over the next two years. 
The strategic plan is available for download from our website aldp.ie. 
In 2018, we delivered direct services in the 
Midwest and Dublin Regions, where we have 
a number of teams operating. Aside from 
service delivery, we continued to advocate 
for drug policies that will make a difference 
in the lives of people who access our 
services, collaborating with partners at home 
and abroad.  The CEO’s report covers key 
numbers in relation to service delivery.
September 2018 saw the winding down of 
the ‘Online and Digital Services’ Team at 
Ana Liffey.  The team managed the Drugs.
ie website which had 1,754,779 visits to 
September 2018. During this period, the 
team also received 809 calls through the Live 
Helper chat service. We are very proud of this 
work over the many years we delivered the 
service, and all during a period of significant 
innovation in the online environment when, 
for example, social media was in its infancy 
and online tools were being developed.  I am 
happy that Ana Liffey played a leading role in 
this regard.
As always, I’d like to take this opportunity 
to express a few words of thanks. First, to all 
those who make the choice to access our 
services, trust us to help with their challenges 
and welcome us into their lives. Thank you. 
You make the Ana Liffey what it is. Second, 
to all our staff, volunteers, interns, and 
students. You all work hard to provide and 
support services that make a difference in 
people’slives – I know that it is not always an 
easy thing to do, but I can tell you that it is 
always an important thing to do. Third, to all 
our funders – you make it possible for us to 
do what we do, and we are very grateful for 
your ongoing support. To my fellow volunteer 
board members – it takes significant 
commitment to be a board member of a civil 
society organisation like Ana Liffey – many 
thanks for giving your time and expertise. 
It’s much appreciated. Finally, I’d also like 
to extend both my personal thanks and 
the thanks of the organisation to Dr. Austin 
O’Carroll who stepped down from the board 
in 2018 – thank you. Austin has been (and still 
is) a great advocate for the Ana Liffey Drug 
Project and the work we do; over the years 
his insight and understanding contributed 
greatly to the board’s work over his time with 
us.
At Ana Liffey, our vision is for a society where 
all people affected by problem substance 
use are treated with dignity and respect and 
have access to quality services. Our mission 
is to work with people affected by problem 
substance use and the organisations that 
support them. We do this to reduce harm 
to individuals and society and to provide 
opportunities for development of those 
individuals and organisations. In recent 
years, we have seen positive steps towards 
our vision, but unfortunately people who 
use drugs still experience significant stigma 
and judgment which can impact negatively 
on their lives and the lives of those around 
them, but does nothing to help address drug 
use and the harm it can cause our citizens 
and communities. We are committed to 
changing this narrative, working towards a 
world in which we focus on reducing harm, 





In 2018, Ana Liffey Drug Project had an income of €2,020,117 (2017 - €1,986,139). It had 
expenditure of €1,979,786 (2017 - €1,997,865 excl. exceptional expenses).
At the end of the year the company had 
fi xed assets of €846,042 (2017: €849,108), 
current assets of €775,314 (2017 €597,773) 
and current liabilities of €386,686 (2017: 
€252,542). The net funds of the company 
amounted to €1,234,670 (2017: €1,194,339) 
and the directors are satisfi ed with the level 
of retained reserves at the year end.
As we had done in 2017, our 2018 company 
fi nancial statements were prepared in 
accordance with the FRS 102 Charities 
SORP, which we have adopted voluntarily 
as a matter of good practice. In addition 
to reporting in compliance with the 
charities SORP, the board keep a view on 
fi nancial matters with a fi nancial update 
at every board meeting as well as quarterly 
meetings of the Finance Sub-Committee.
The Ana Liffey Drug Project receives 
funding throughout the year from a 
number of statutory and non-statutory 
funders, as well as from public donations. 
We’re very grateful to everyone who 
contributes to the running of the 
organisation. 
I’d also like to express my thanks to the 
management team of the organisation, 
and in particular to Leonie Blyth, and also 
to our auditors, Donal Ryan and Associates, 
and in particular to Donal and Paula for 
their work during the year in ensuring the 
company monitors and reports accurately 
on fi nancial matters.  
Finally, the company’s full fi nancial 






A year is a long time in the life of an organisation, something which is always apparent when 
we pause to look back at the previous year’s work. 
Our new strategic plan – Safer From Harm 
– covers the period 2018-2020, so 2018 saw 
the fi rst year of activity under the strategy. 
Working for the benefi t of people who use 
drugs and who have complex and multiple 
needs - we trained our team and further 
developed our systems, across our Midwest 
Region and Dublin Services, to increase 
our capacity to deliver care planning.  In 
Dublin, we further developed our frontline 
service provision in partnership with An 
Garda Síochána, Dublin City Council and the 
Health Service Executive. With the support 
of the festival promoter, Ana Liffey expanded 
our team of volunteers to provide Festival 
Welfare service at Electric Picnic. Separately, 
we also worked in partnership with the 
HSE to develop a cocaine harm reduction 
campaign.
In relation to our work on policy and 
participation, working in partnership we 
got the #saferfromharm campaign up and 
running – raising awareness of the issue of 
the criminalisation of people who use drugs, 
and publishing a paper with the London 
School of Economics. We also continued 
our work with partners in Europe, working 
to ensure civil society organisations have a 
voice in the policy arena.
Of course, all of these strategic 
developments were archived whilst 
delivering our frontline services. The 
following highlights our signifi cant day-to-
day frontline operations:
Dublin Services
In 2018, the open access provided services 
to 982 individuals the majority of people 
were homeless and many of whom were 
poly drug users with mental and physical 
health problems; 151 individuals received key 
working and case management; 437 people 
attended treatment groups; 538 individuals 
used the needle and syringe programme. We 
also provided in-reach services to Mountjoy 
Prison and 54 individuals attended groups 
run in this setting.
Mid-West Services
In the Midwest we served a similar cohort 
of people, 281 people were registered with 
the service in 2018. Of these, 75 individuals 
accessed our case management service and 
129 people accessed our needle and syringe 
programme.
North East Needle and Syringe 
Programme
From July 2018, we provided an NSP service 
on an action research basis in the North East 
region. From July 2018 to the end of 2018, 57 
individuals accessed this service.
Volunteerism
81 people volunteered their time with the 
organisation in 2018 across all front line 
services, central offi ce and festival welfare 
services.
Finally, I’d like to thank everyone who 
contributes to making the Ana Liffey what 
it is – our funders, our staff, our board and 
other volunteers, our interns and students, 
and, most importantly, the people for whom 
we provides services – thank you all. Together 
we are all much more than the sum of
our parts, and it is a great pleasure to







The Board (as at 31st December 2018) was:









The Board met 6 times in 2018. The Board has three subgroups – on Finance; 
Clinical Governance; and Governance and Human Resources – all of which meet 
quarterly, and are supported by the management team. The membership of 
each group is set out below:
Finance
 Greg Ward (Chair)
 Edward Matthews
Clinical Governance
 Alice O’Flynn (Chair)
 Austin O’Carroll
 Mike Scully (External)
Governance and HR
 Roderick Maguire (Chair)
 Brian Dalton
The staff team (as at 31st December 2018) was:
Tony Duffin Chief Executive Officer
Dawn Russell Head of Services
Marcus Keane Head of Policy
Leonie Blyth Head of Finance
Jacqueline Kenny Office Administrator 
Jennifer McCusker Administrative Assistant
Rachel O’Donoghue Team Leader
Aoife Marshall Project Worker
Pat Galligan Project Worker
Lynn Collopy Project Worker
Tris O’Loughlin Project Worker
Martina Bergin  Team Leader
Natasha Gannon Project Worker
Alison Harte Project Worker 
Shawneen Doonan Project Worker
JM Burr Team Leader
Ross McNulty  Team Leader
Jade McGroarty-Barry RGN
Lena Kattendick Project Worker
Evonne Mushonga Project Worker
Rory More-O’Ferrall Project Worker
Rebecca Doyle Project Worker
Miranda O’Sullivan Project Worker
John Burke Project Worker
Rachel Fayne Project Worker
Peter Bennewith Project Worker
John O’Meara  Project Worker
Damien Gagnevin Project Worker
Niamh Foley Project Worker 
Staff
Thank you to everyone who 
contributes to making the Ana 
Liffey what it is – our funders, 
our staff, our board and other 
volunteers, our interns and 
students, and, most importantly, 
the people for whom we provides 
services – thank you all. 
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